Original Publication Date: 1 July, 2017
Publication / Source: Pain Management
Authors: Charles A Odonkor, Gabriel Kim & Michael Erdek
Aim: Despite the rise in cancer survivorship, few reviews have examined the quality of studies of cancer pain management and practices around the globe. With a void in trials spanning multiple geographical settings, this review evaluates the quality of cancer trials across three continents. Materials & methods: A literature review and search of established databases was conducted to identify eligible studies. The Cochrane method, the Jadad Score and a cancer pain-specific ad hoc tool were used to evaluate quality of studies.
Although advances in cancer treatments have helped to increase cancer survivorship, there has not been a concomitant improvement in cancer pain outcomes globally [1,2]. The literature indicates that approximately 60% of survivors continue to have poor quality of life as a result of undertreated cancer pain . Due to differences in geopolitical, financial-legal and sociocultural influences on evidence-based practice, there is a wide variability in treatment, which results in very disparate outcomes for patients [4–6].
Click here to read the full article in Pain Management.